Tag: Leukemia

Loss of protein p53 helps cancer cells multiply in ‘unfavourable’ conditions: The loss of tumor protein p53 ensures cancer cells can still multiply in a hostile environment that lacks proper growth stimuli

Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife. The study in mouse and human cells, from the Netherlands Cancer Institute, suggests that multiplication of cancer cells in the absence of appropriate growth stimuli is supported by the additional loss of

Cancer hijacks the microbiome to glut itself on glucose

Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption — where there is consumption, there is cancer. But how does cancer get this glucose? A University of Colorado

Immediate compression could help prevent complications after deep-vein thrombosis: Study supports use of this simple, low-cost intervention even for patients without symptoms

People with deep-vein thrombosis (DVT) can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy in the first twenty-four hours of DVT therapy (known as the acute phase of treatment), suggests a study published today in the journal Blood. DVT occurs when a blood clot forms in a deep vein, commonly

Mitochondria come together to kill cancer cells: Uncovered details of a molecular pathway in cancer cells could lead to improved treatment

A team of Hokkaido University scientists studied the molecules involved in mitochondrial movements within highly invasive breast cancer cells. They identified a pathway that ultimately leads to the dispersion of these energy-generating organelles towards the cells’ periphery, increasing cancer invasiveness. When this pathway was blocked, mitochondria aggregated within the cell’s center, where they started overproducing

Major new vulnerability of childhood leukemia uncovered

Childhood leukemia is a diagnosis that no family ever wants to endure. While the treatment of most types of leukemia has improved steadily over the years, a few specific types remain very difficult to treat. One of these is called “mixed lineage leukemia,” and for children affected by this cancer, their chance of survival is

Kidney cancer’s developmental source revealed: First human kidney cell atlas study across the human lifespan

In the first experiment of its kind, scientists have revealed the precise identity of cancer cells of the most common childhood and adult kidney cancers. Researchers from the Wellcome Sanger Institute, the University of Cambridge, University of Newcastle and their collaborators showed that the cancer cells are versions of specific healthy cells from developing or

Mechanisms of action of key genetic abnormality in Ewing sarcoma: Epigenome editing reveals how a fusion protein found in cancer cells enhances the expression of target genes

A Massachusetts General Hospital (MGH) research team has used epigenome editing tools to investigate how the genetic abnormality that drives Ewing sarcoma — the second most common bone cancer in children and young adults — unleashes tumor growth. In their paper in the journal Genes & Development the researchers show that blocking the fusion protein

Novel bioengineering technique for personalized bone grafts: Scientists optimize a procedure toward regenerative medicine for bone defects

Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique, described in a paper published online today in Scientific Reports, allows researchers to combine segments of bone engineered from stem cells to create large scale, personalized grafts that will

Researchers solve mystery of how ALL enters the central nervous system: Rather than breach the blood-brain barrier, the leukemia cells use a unique pathway

A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system. ALL in the central nervous system is very difficult to treat, because most drugs are blocked from the organ system due to a “blood-brain barrier” designed to protect the brain. How cancer cells enter the central nervous system has

Rise of the clones: Study identifies inherited and acquired mutations that drive precancerous blood condition

A new study led by researchers at Harvard Medical School and the Harvard T.H. Chan School of Public Health has identified some of the first known inherited genetic variants that significantly raise a person’s likelihood of developing clonal hematopoiesis, an age-related white blood cell condition linked with higher risk of certain blood cancers and cardiovascular

A study points to new therapeutic targets for tumors associated with chronic inflammation: A new study demonstrates that myeloid cells use p38 protein signalling to support inflammation-associated colon cancer

Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. The study has been published in the journal EMBO Molecular Medicine. More than a million people worldwide are diagnosed

Roots of leukemia reveal possibility of predicting people at risk

Scientists have discovered that it is possible to identify people at high risk of developing acute myeloid leukaemia (AML) years before diagnosis. The researchers from Wellcome Sanger Institute, European Bioinformatics Institute (EMBL-EBI) and their international collaborators found that patients with AML had genetic changes in their blood years before they suddenly developed the disease. The

Childhood cancer: The four survival strategies of tumor cells

Cancer cells in children tend to develop by following four main trajectories — and two of them are linked to relapse of the disease, research led by Lund University in Sweden shows. The four strategies can occur simultaneously in a single tumour, according to the study that is now published in Nature Genetics. The researchers

CLL patient goes into remission thanks to single CAR T cell: Case study provides clues that could help improve response rates

The doctors who have spent years studying the case call it “a series of fortunate events.” What began as a remarkable response to chimeric antigen receptor (CAR) T cell therapy is now providing evidence about the human genome and immune response that could help turn gene therapy non-responders into responders. Researchers at the University of

Embryonic mammary gland stem cells identified: Researchers define for the first time the mechanisms responsible for the mammary gland development

Publication in Nature Cell Biology: researchers at the Université libre de Bruxelles, ULB define for the first time the mechanisms responsible for the mammary gland development. The mammary gland is the tissue that produces the milk during lactation, allowing the survival of young mammalian offspring. The mammary gland is composed of two main lineages: the

More patients with severe alcoholic hepatitis receiving liver transplants: Medical centers willing to perform transplants without mandated six-month wait

Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease Week® (DDW) 2018. Study implications “Liver transplant for severe alcoholic hepatitis is being increasingly

Trial shows chemotherapy is helping kids live with pulmonary vein stenosis: Adding chemotherapy to a treatment regimen including catheterization and surgery can deter abnormal cellular growth

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated. Typically affecting young children, the most severe form of PVS progresses very